Will These Biotechs Gap Up Big Like SRNE?

Edward Lance lorilla,  The markets opened down on Friday, following the news that President Trump has tested positive for Covid-19.     It's created a lot of uncertainty, and has traders wondering...   Do we sit on the sidelines, be aggressive, sell?   The market may look higher risk overall, but it's also shifted attention back into the biotech sector.     Which is why Kyle Dennis will be looking for opportunities there for his next Fast 5 trade on Monday... "I think the news will bring back into focus again the covid stocks. Diagnostics, therapeutics, vaccines, and even masks etc. I traded SRNE last week, which is an early stage vaccine candidate, and I might trade a similar type of company on Monday." When Kyle alerted his SRNE trade on Monday, he was hoping for a potential press release on COVI-STIX, one of SRNE's antiviral therapies. On Monday night, it just so happened that some positive news broke, regarding two of its other therapies in progress, COVI-Guard and COVI-AMG.      Kyle immediately sold his SRNE shares in the premarket Tuesday morning for a nice $3,400 win.    >> WATCH: How Kyle Finds Catalyst Plays like SRNE<<   So what COVID stock might Kyle alert in Fast 5 Trades on Monday? It's too early to be certain, but we got with Kyle and he likes these names...   Fluidigm Corporation (FLDM):   FLDM focuses on developing tools and technologies for life sciences research worldwide On August 26th, the company reported it had received emergency-use authorization from US FDA for its coronavirus test. The stock gapped up as high as $12.45 on the news FLDM has been trading in a daily range from $6 to $9 since its initial gap and is now finding significant support  We like this pattern for Monday, looking for continuation of momentum to the upside. Key support areas to watch for are $7.5, $8. We want to see the stock get above its previous pivot high of $8.87 and break above $9, for a potential explosive move higher     Alpha Pro Tech (APT): APT develops and manufactures disposable protective apparel and consumer products, all to service the medical, dental, and consumer industry This stock historically has been an explosive mover on any pandemic-related news whenever the demand for masks and protective suits is expected to increase Back in March, APT went as high as $41.59 in just 4 days. It had multiple smaller runs to $20 and $25 since then APT has been building a small base in the $13.6 area and gapped up on Friday after the headline. We would like to keep this one on our watchlist for a move above $17, where we could see a start to an outsized move higher. It needs to hold above $15.5 and ideally continue to close above $16 for the confirmation of strength     AIM Immunotech (AIM): AIM focuses on research and development of therapeutics. Its main drug, Ampligen, is aimed to improve conditions in patients with pancreatic cancer after chemotherapy Just recently, AIM has struck an agreement with Roswell Park Comprehensive Care Center to use Ampligen in combination with Interferon alfa-2b to research the effects on cancer patients with COVID-19 The stock is in a tight consolidation on the daily chart, trading around $2.1 on low volume. Despite the low average daily volume, we like how the chart is holding up Should this company get a PR out, we think the stock could easily get above $3. While we do need to see some confirmation first, we will make sure to keep it on our watchlist       To learn exactly what Kyle is trading on Monday, join his Fast 5 Trades service here.  And make sure to check out this video on how Kyle finds catalyst plays, just like last Monday's winner in SRNE:           Declutter Your Trading And Focus On What Matters By Ben Sturgill of Daily Profit Machine Don't Let The Media Fool You By JC Parets of Chart Hunter Volatility Exploding: My Plans Right Now By Jason Bond of Weekly Windfalls How Do You Generate Trade Ideas? By Kyle Dennis of Biotech Breakouts RagingBull, LLC 62 Calef Hwy. #233, Lee, NH 03861 Click Here to stop receiving emails from support@ragingbull.com Unsubscribe from all RagingBull emails DISCLAIMER: To more fully understand any Ragingbull.com, LLC ("RagingBull") subscription, website,application or other service ("Services"), please review our full disclaimer located at https://ragingbull.com/disclaimer. FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. AnyRagingBull Service offered is for educational and informational purposes only and should NOT beconstrued as a securities-related offer or solicitation, or be relied upon as personalizedinvestment advice. RagingBull strongly recommends you consult a licensed or registered professional before making any investment decision. RESULTS PRESENTED NOT TYPICAL OR VERIFIED. RagingBull Services may contain information regarding the historical trading performance of RagingBull owners or employees, and/or testimonials of non-employees depicting profitability that are believed to be true based on the representations of the persons voluntarily providing the testimonial. However, subscribers' trading results have NOT been tracked or verified and past performance is not necessarily indicative of future results, and the results presented in this communication are NOT TYPICAL. Actual results will vary widely given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. Investing in securities is speculative and carries a high degree of risk; you may lose some, all, or possibly more than your original investment. RAGINGBULL IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Neither RagingBull nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor(IA), or IA representative with the U.S. Securities and Exchange Commission, any state securitiesregulatory authority, or any self-regulatory organization. WE MAY HOLD SECURITIES DISCUSSED. RagingBull has not been paid directly or indirectly by the issuer of any security mentioned in the Services. However, Ragingbull.com, LLC, its owners, and itsemployees may purchase, sell, or hold long or short positions in securities of the companies mentioned inthis communication.